Redeye: QleanAir - Still Too Cheap Despite Downgrade
Redeye lowers its expectations on profitability for the coming quarters following a report that missed our EBIT forecast. The lower forecast accompanied by an increase in our risk-free rate, results in a downgraded base case valuation. Even if the near-term outlook again, is somewhat more uncertain with mixed performance between segments, we continue to identify a solid upside in the share, arguing that the market does not price in future growth at current multiples of P/E 10-7.5x or 12-10.3x EV/FCF for FY23-24e.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/